ADARx Pharmaceuticals
Mr. Chimovits has 14 years of operational experience, including 10 years of senior managerial experience in public companies. Prior to joining OrbiMed Mr. Chimovits was the CEO of NasVax (TASE:NSVX). Previously, Mr. Chimovitz spent seven years with Compugen (Nasdaq:CGEN), as President, Compugen USA Inc. and Executive V.P., Commercial Operations. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions including with J&J, Novartis, Teva, Abbott, Medarex and others.
Mr. Chimovits earned his M.B.A., M.Sc. in Microbiology and his B.Sc. from Tel Aviv University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
ADARx Pharmaceuticals
4 followers
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.